Phase 1 Parkinson's Disease Trial, Recruiting NCT05152394 Sponsor: The Foundation for Orthopaedics and Regenerative Medicine Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 1 Parkinson's Disease Trial, Recruiting

NCT05152394
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's Disease
  • You are able to understand the study information and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • You currently have an active infection
  • You currently have active cancer
  • You have serious failure of multiple organs in your body at the same time
  • You are pregnant
  • Your pre-treatment blood or lab test results show significant abnormalities
  • You have a medical condition that the trial doctor believes could put your safety at risk (confirm with trial site)
  • You are currently misusing or abusing drugs
  • You are a woman who has not yet gone through menopause and is not using a form of contraception
  • You have previously had an organ transplant
  • You have a known allergy or sensitivity to sulfur
  • You are currently taking blood-thinning (anticoagulant) medication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Registry
ClinicalTrials.gov
Start date
17 August 2024
Est. completion
1 January 2027

Where this trial is recruiting

Antigua and Barbuda

Primary endpoints

Safety (adverse events)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov